Inventor · disambiguated record
Peter A. Virsik
Also filed as: VIRSIK PETER · VIRSIK PETER A · VIRSIK PETER ANDREW
21 granted patents·38 pending applications·246 citations·filing 2007–2024
95Inventor score
Files withXENOPORT INC20ESSA PHARMA INC18ARBOR PHARMACEUTICALS LLC11GANGAKHEDKAR ARCHANA3JANDELEIT BERND3
Top patents by PatentIndex Score
59 records- 0198US11358938B2Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereofESSA PHARMA INC·Filed 2021·Granted Jun 14, 2022·8 cites·26 claims
- 0298US11242324B2Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereofESSA PHARMA INC·Filed 2021·Granted Feb 8, 2022·9 cites·25 claims
- 0397US11518747B2Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereofESSA PHARMA INC·Filed 2022·Granted Dec 6, 2022·6 cites·30 claims
- 0497US11059795B2Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2020·Granted Jul 13, 2021·12 cites·25 claims
- 0596US8778991B2Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of useGANGAKHEDKAR ARCHANA·Filed 2011·Granted Jul 15, 2014·66 cites·9 claims
- 0696US8148414B2Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of useGANGAKHEDKAR ARCHANA·Filed 2009·Granted Apr 3, 2012·65 cites·22 claims
- 0794US11814357B2Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereofESSA PHARMA INC·Filed 2022·Granted Nov 14, 2023·1 cites·22 claims
- 0894US11485713B2Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2019·Granted Nov 1, 2022·10 cites·28 claims
- 0993US7994218B2Simple pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of useXENOPORT INC·Filed 2008·Granted Aug 9, 2011·14 cites·21 claims
- 1091US8785443B2Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereofGANGAKHEDKAR ARCHANA·Filed 2011·Granted Jul 22, 2014·16 cites·42 claims
- 1190US8168617B2Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of useJANDELEIT BERND·Filed 2008·Granted May 1, 2012·24 cites·25 claims
- 1285US10716760B2Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofXENOPORT INC·Filed 2016·Granted Jul 21, 2020·2 cites·18 claims
- 1385US7868043B2Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of useXENOPORT INC·Filed 2009·Granted Jan 11, 2011·7 cites·24 claims
- 1485US2024051926A1Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereofESSA PHARMA INC·Filed 2023·Application pending·0 cites
- 1583US7872046B2Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of useXENOPORT INC·Filed 2009·Granted Jan 18, 2011·4 cites·27 claims
- 1682US10940117B2Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofARBOR PHARMACEUTICALS LLC·Filed 2020·Granted Mar 9, 2021·1 cites·12 claims
- 1780US2024240229A1Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effectsARBOR PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 1879US2024024249A1Oral dosage forms having a high loading of a methyl hydrogen fumarate prodrugARBOR PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 1978US10945984B2Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effectsARBOR PHARMACEUTICALS LLC·Filed 2013·Granted Mar 16, 2021·1 cites·12 claims
- 2077US2020087272A1Treatment of multiple sclerosis and psoriasis using prodrugs of methyl hydrogen fumarateARBOR PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
- 2176US2021179573A1Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen FumarateARBOR PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 2274US2021323931A1Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereofESSA PHARMA INC·Filed 2021·Application pending·0 cites
- 2372US2024261282A1Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereofESSA PHARMA INC·Filed 2024·Application pending·0 cites
- 2471US2024197661A1Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofARBOR PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 2570US2021145755A1Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofARBOR PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 2669US2019256481A1Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen FumarateARBOR PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
- 2769US2019256480A1Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen FumarateARBOR PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
- 2869US2022380325A1Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2021·Application pending·0 cites
- 2967US2020123117A1Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2019·Application pending·0 cites
- 3067US2018237405A1Treatment of multiple sclerosis and psoriasis using prodrugs of methyl hydrogen fumarateXENOPORT INC·Filed 2018·Application pending·0 cites
- 3167US2018273500A1Treatment of multiple sclerosis and psoriasis using prodrugs of methyl hydrogen fumarateXENOPORT INC·Filed 2018·Application pending·0 cites
- 3266US2022105093A1Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereofESSA PHARMA INC·Filed 2021·Application pending·0 cites
- 3364US2013324539A1Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen FumarateXENOPORT INC·Filed 2013·Application pending·0 cites
- 3463US9452972B2Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereofXENOPORT INC·Filed 2014·Granted Sep 27, 2016·0 cites·12 claims
- 3562US2023373934A1Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2023·Application pending·0 cites
- 3661US9597292B2Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofXENOPORT INC·Filed 2013·Granted Mar 21, 2017·0 cites·4 claims
- 3761US2020000758A1Oral Dosage Forms Of Methyl Hydrogen Fumarate And Prodrugs ThereofXENOPORT INC·Filed 2019·Application pending·0 cites
- 3861US2024398797A1Combination therapies for metastatic castration-resistant prostate cancerJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 3961US2021228525A1Methods of Administering Monomethyl Fumarate and Prodrugs Thereof Having Reduced Side EffectsARBOR PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 4061US2009076141A1Use of Propofol Prodrugs for Treating Neuropathic PainXENOPORT INC·Filed 2008·Application pending·0 cites
- 4160US2024358701A1Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereofESSA PHARMA INC·Filed 2022·Application pending·0 cites
- 4260US2024207264A1Pharmaceutical compositions comprising inhibitors of the androgen receptor and uses thereofESSA PHARMA INC·Filed 2022·Application pending·0 cites
- 4358US12109179B2Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereofESSA PHARMA INC·Filed 2020·Granted Oct 8, 2024·0 cites·23 claims
- 4458US2015252013A1Treatment of multiple sclerosis and psoriasis using prodrugs of methyl hydrogen fumarateXENOPORT INC·Filed 2015·Application pending·0 cites
- 4558US2022380378A1Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2022·Application pending·0 cites
- 4657US2007259933A1Compositions, dosage forms and methods of treating emesisXENOPORT INC·Filed 2007·Application pending·0 cites
- 4754US2009099253A1Internally Masked Neopentyl Sulfonyl Ester Cyclization Release Prodrugs of Acamprosate, Compositions Thereof, and Methods of UseXENOPORT INC·Filed 2008·Application pending·0 cites
- 4853US2015307914A9Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effectsXENOPORT INC·Filed 2014·Application pending·0 cites
- 4951US2022202780A1Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereofESSA PHARMA INC·Filed 2020·Application pending·0 cites
- 5050US2009118365A1Use of Prodrugs of GABA B Agonists for Treating Neuropathic and Musculoskeletal PainXENOPORT INC·Filed 2008·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →